Alnylam Pharmaceuticals
Clinical trials sponsored by Alnylam Pharmaceuticals, explained in plain language.
-
New drug aims to lighten heavy periods for bleeding disorder patients
Disease control Not yet recruitingThis study tests an investigational drug called ALN-6400 in 24 women and teens with von Willebrand disease who have heavy menstrual bleeding. The goal is to see if the drug is safe and can reduce bleeding. Participants will receive multiple doses and be monitored for side effects…
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for Alzheimer's in down syndrome: drug trial launches
Disease control Not yet recruitingThis study tests a drug called mivelsiran in 58 adults with Down syndrome who have early-stage Alzheimer's. Participants receive either the drug or a placebo via injection into the spine every few months for two years. The goal is to see if the drug can reduce brain changes linke…
Phase: PHASE2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC